Search

Author/Creator Tiseo, M

1. 10P Genetic, tissue and circulating PD-L1 profiling to predict the response to immuno-checkpoint inhibitors in advanced NSCLC. (15th December 2019)

Authors:
Mazzaschi, G; Minari, R; Ferri, V; Gnetti, L; Bersanelli, M; Cavazzoni, A; Bordi, P; Squadrilli, A; Buti, S; Cosenza, A; Ferri, L; Rapacchi, E; Petronini, P G; Missale, G; Quaini, F; Tiseo, M
Journal:
Annals of oncology
Issue:
Volume 30(2019)Supplement 11
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 1818TiPMulticentre, double-blind, randomised phase II study evaluating gemcitabine with or without ramucirumab as II line treatment for MPM. (23rd October 2018)

Authors:
Pagano, M; Zanelli, F; Gnoni, R; Bonelli, C; Tiseo, M; Boni, L; Ceresoli, G L; Zucali, P A; Grosso, F; Pasello, G; Cappuzzo, F; Pinto, C
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. 1OAdvanced CT imaging features reflect distinct tissue immune profiles and exhibit high prognostic impact on NSCLC. (17th December 2018)

Authors:
Mazzaschi, G; Pagano, P; Milanese, G; Madeddu, D; Falco, A; Armani, G; Bocchialini, G; Marturano, D; Ampollini, L; Lorusso, B; Lagrasta, C; Sverzellati, N; Silva, M; Tiseo, M; Quaini, F; Roti, G
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 10
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. 466OASTRIS real world study of osimertinib in patients (pts) with EGFR T790M NSCLC: Efficacy analysis by tissue or plasma T790M test. (25th November 2018)

Authors:
Freitas, H C; Park, K; Kim, D-W; Tiseo, M; Hochmair, M J; Chang, G-C; Shi, Y-K; Moran, T; Chen, Y; Laskin, J; Solomon, B; Miranda, M; Rigas, J; Cheema, P K; Kim, S-W
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 9
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. LBA16Osimertinib vs comparator EGFR-TKI as first-line treatment for EGFRm advanced NSCLC (FLAURA): Final overall survival analysis. (24th November 2019)

Authors:
Cho, B C; Ohe, Y; Zhou, C; Reungwetwattana, T; Cheng, Y; Chewaskulyong, B; Lee, K H; Planchard, D; Vansteenkiste, J F; Gray, J E; Shah, R; Cheema, P K; Tiseo, M; John, T; Hodge, R; Rukazenkov, Y; Soria, J-C; Lin, M-C; Imamura, F; Ramalingam, S S
Journal:
Annals of oncology
Issue:
Volume 30(2019)Supplement 9
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. LBA1Brigatinib vs crizotinib in patients with ALK inhibitor-naive advanced ALK+ NSCLC: Updated results from the phase III ALTA-1L trial. (24th November 2019)

Authors:
Camidge, R; Kim, H R; Ahn, M-J; Yang, J C-H; Han, J-Y; Hochmair, M J; Lee, K H; Delmonte, A; Garcia Campelo, M R; Kim, D-W; Griesinger, F; Felip, E; Califano, R; Spira, A; Gettinger, S; Tiseo, M; Ni, Q; Zhang, P; Popat, S
Journal:
Annals of oncology
Issue:
Volume 30(2019)Supplement 9
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. LBA58Intracranial efficacy of brigatinib (BRG) vs crizotinib (CRZ) in the phase III ALTA-1L trial. (23rd October 2018)

Authors:
Popat, S; Kim, H R; Ahn, M-J; Yang, J C-H; Han, J-Y; Hochmair, M J; Lee, K H; Delmonte, A; Garcia Campelo, M R; Kim, D-W; Griesinger, F; Felip, E; Califano, R; Spira, A I; Gettinger, S; Tiseo, M; Haney, J; Kerstein, D; Camidge, D R
Journal:
Annals of oncology
Issue:
Volume 29(2018)Supplement 8
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Soluble PD-L1 and Circulating CD8+PD-1+ and NK Cells Enclose a Prognostic and Predictive Immune Effector Score in Immunotherapy Treated NSCLC patients. (October 2020)

Authors:
Mazzaschi, G.; Minari, R.; Zecca, A.; Cavazzoni, A.; Ferri, V.; Mori, C.; Squadrilli, A.; Bordi, P.; Buti, S.; Bersanelli, M.; Leonetti, A.; Cosenza, A; Ferri, L.; Rapacchi, E.; Missale, G.; Petronini, P.G.; Quaini, F.; Tiseo, M
Journal:
Lung cancer
Issue:
Volume 148(2020)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗